EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.7

Maternal-fetal interfaces transcriptome changes associated with placental insufficiency and a novel gene therapy intervention

Helen N Jones iD, Baylea N Davenport iD, Rebecca L Wilson iD

Physiological Genomics · 2025

DOI: 10.1152/physiolgenomics.00131.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiological Genomics, 2025. Verfasst von Helen N Jones und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Aging, College of Medicine, University of Florida, Gainesville, Florida, United States. Hauptthemen laut MEDLINE: Placental Insufficiency, Fetal Growth Retardation, Transcriptome, Insulin-Like Growth Factor I. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.7). Gefördert von: NICHD NIH HHS, HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Placental insufficiency at midpregnancy, established through moderate maternal nutrient restriction, is characterized with fewer maternal spiral arteries lined by trophoblast, shallower trophoblast invasion, and downregulation of genelists involved in the regulation of cell migration. Treatment of placenta insufficiency with a hIGF1 nanoparticle results in marked changes to transporter activity and increases our mechanistic understanding of how therapies designed to improve fetal growth may impact the placenta.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Placental InsufficiencyFetal Growth RetardationTranscriptomeInsulin-Like Growth Factor ITrophoblastsGenetic TherapyFemaleAnimalsPregnancyGuinea PigsPlacentaHumansNanoparticlesDisease Models, Animal

Stichwörter der Autor:innen

IGF1fetal growth restrictionnanoparticleplacental insufficiencytrophoblast invasion

Substanzen

Insulin-Like Growth Factor IIGF1 protein, human

Autor:innen und Institutionen

  • Department of Physiology and Aging, College of Medicine, University of Florida, Gainesville, Florida, United States.
  • Center for Research in Perinatal Outcomes, College of Medicine, University of Florida, Gainesville, Florida, United States.

ORCID-Profile: Helen N Jones, Baylea N Davenport, Rebecca L Wilson

Förderung

  • NICHD NIH HHS
  • HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Zitieren

APA

Jones, H. N., Davenport, B. N., & Wilson, R. L. (2025). Maternal-fetal interfaces transcriptome changes associated with placental insufficiency and a novel gene therapy intervention. Physiological Genomics. https://doi.org/10.1152/physiolgenomics.00131.2024

Vancouver

Jones HN, Davenport BN, Wilson RL. Maternal-fetal interfaces transcriptome changes associated with placental insufficiency and a novel gene therapy intervention. Physiological Genomics. 2025. doi:10.1152/physiolgenomics.00131.2024

BibTeX
@article{Jones2025,
  author = {Jones, Helen N and Davenport, Baylea N and Wilson, Rebecca L},
  title = {Maternal-fetal interfaces transcriptome changes associated with placental insufficiency and a novel gene therapy intervention},
  journal = {Physiological Genomics},
  year = {2025},
  doi = {10.1152/physiolgenomics.00131.2024}
}
Kostenlos starten →